Stryker Q2 - Elective Surgery Down
Last week Stryker reported Q1 earnings. As a medical device business, this company stands to be hard hit by COVID-19. Most of their equipment relies on elective surgeries like hip and knee replacements. The share price is down 20% from its February highs so the market has factored in a lot of this already.